161 related articles for article (PubMed ID: 21458433)
1. Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations.
Gomaraschi M; Obici L; Simonelli S; Gregorini G; Negrinelli A; Merlini G; Franceschini G; Calabresi L
Clin Chim Acta; 2011 Jun; 412(13-14):1262-5. PubMed ID: 21458433
[TBL] [Abstract][Full Text] [Related]
2. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
[TBL] [Abstract][Full Text] [Related]
4. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
Daniil G; Phedonos AA; Holleboom AG; Motazacker MM; Argyri L; Kuivenhoven JA; Chroni A
Clin Chim Acta; 2011 Jun; 412(13-14):1213-20. PubMed ID: 21420943
[TBL] [Abstract][Full Text] [Related]
6. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.
Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM
J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.
Gursky O; Mei X; Atkinson D
Biochemistry; 2012 Jan; 51(1):10-8. PubMed ID: 22229410
[TBL] [Abstract][Full Text] [Related]
9. Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
Leren TP; Bakken KS; Daum U; Ose L; Berg K; Assmann G; von Eckardstein A
J Lipid Res; 1997 Jan; 38(1):121-31. PubMed ID: 9034206
[TBL] [Abstract][Full Text] [Related]
10. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
[TBL] [Abstract][Full Text] [Related]
11. Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency.
von Eckardstein A; Huang Y; Wu S; Funke H; Noseda G; Assmann G
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):691-703. PubMed ID: 7749883
[TBL] [Abstract][Full Text] [Related]
12. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
13. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
[TBL] [Abstract][Full Text] [Related]
14. Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux.
Nilsson O; Lindvall M; Obici L; Ekström S; Lagerstedt JO; Del Giudice R
J Lipid Res; 2021; 62():100004. PubMed ID: 33410751
[TBL] [Abstract][Full Text] [Related]
15. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
Sparks DL; Frank PG; Neville TA
Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
[TBL] [Abstract][Full Text] [Related]
16. Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins.
Wilson CJ; Das M; Jayaraman S; Gursky O; Engen JR
Biochemistry; 2018 Jul; 57(30):4583-4596. PubMed ID: 30004693
[TBL] [Abstract][Full Text] [Related]
17. Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis.
Gregorini G; Izzi C; Ravani P; Obici L; Dallera N; Del Barba A; Negrinelli A; Tardanico R; Nardi M; Biasi L; Scalvini T; Merlini G; Scolari F
Kidney Int; 2015 Jun; 87(6):1223-9. PubMed ID: 25565309
[TBL] [Abstract][Full Text] [Related]
18. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
19. Autophagy Alteration in ApoA-I Related Systemic Amyloidosis.
Del Giudice R; Imbimbo P; Pietrocola F; Martins I; De Palma FDE; Bravo-San Pedro JM; Kroemer G; Maiuri MC; Monti DM
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408859
[TBL] [Abstract][Full Text] [Related]
20. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L
Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
